{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-023109","form_type":"8-K","ticker":"XTNT","cik":"0001453593","company_name":"Xtant Medical Holdings, Inc.","filed_at":"2025-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.021225+00:00","generated_at":"2026-05-17T14:25:31.227146+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Xtant Medical Q2 2025 revenue $35.4M (+18% YoY), net income $3.6M, raises FY guidance","bullets":["Revenue $35.4M up 18% YoY; gross margin improved to 68.6% from 62.1%.","Net income $3.6M ($0.02 diluted EPS) vs net loss $3.9M in Q2 2024.","Adjusted EBITDA $6.9M vs loss of $0.6M; operating cash flow $1.2M vs use of $5.1M.","FY2025 revenue guidance raised to $131-$135M (prior $127-$131M), growth 11%-15%.","Announced sale of non-core Coflex/CoFix/OUS assets to Companion Spine for ~$19.2M."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-023109","json":"https://secwatch.observer/filing/0001641172-25-023109.json","markdown":"https://secwatch.observer/filing/0001641172-25-023109.md","text":"https://secwatch.observer/filing/0001641172-25-023109.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1453593/000164117225023109/0001641172-25-023109-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1453593/000164117225023109/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T14:25:31.227146+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}